This is an old revision of the document!
Canadian Immunization Research Network
CIRN is a self-described “network of networks” that provides data to inform public health decision-making about immunization programs. CIRN is involved in clinical research, surveillance and epidemiological research, and public health program evaluation. The group's focus is on late-stage vaccine evaluation of program implementation.1)
The program operated as the PHAC/CIHR Influenza Research Network (PCIRN) from 2009-2014 then relaunched as CIRN from June 2014 – May 2017 with a three-year grant of $6.6 million from PHAC and CIHR. A directed CIRN renewal grant application was submitted in February 2017. In April 2017, the network was notified that it is fully funded for $10,083,334 over the next 55 months, 2017-2022.
Funding
CIRN is partnered with and funded by Pfizer, GlaxoSmithKline, Sanofi, Novartis, and VBI Vaccines, as well as the Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada (PHAC).2) 3) 4) 5) 6)
Studies
CANVAS-COVID
The CIRN is running the Canadian National Vaccine Safety (CANVAS) Network, which is a national platform that monitors vaccine safety after vaccines are approved for use.7)
MOSAIC
MOSAIC-1
Annual Reports
Annual reports for these organizations are a gold mine. More to be unearthed from within and added to this page.